"Shah Capital's Push for Novavax Board Shake-Up Amid Vaccine Struggles"
TL;DR Summary
A hedge fund is pushing for a board shake-up at Novavax due to the struggles of its Covid vaccine. The fund is urging the company to consider changes to its board composition in order to improve its performance in the development and distribution of the vaccine.
- Hedge fund urges board shake-up at Novavax over struggling Covid vaccine Financial Times
- Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says MarketWatch
- Shah Capital nominates two highly qualified independent director candidates for Novavax Yahoo Finance
- Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push - TipRanks.com TipRanks
- US-based Hedge fund Shah Capital urges Novavax board shake-up: Report Business Standard
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
59%
112 → 46 words
Want the full story? Read the original article
Read on Financial Times